Gainers
- F-star Therapeutics FSTX stock rose 9.3% to $5.99 during Monday's after-market session. The company's market cap stands at $116.0 million.
- Processa Pharmaceuticals PCSA stock rose 8.6% to $6.56. The market value of their outstanding shares is at $102.1 million.
- Exicure XCUR stock moved upwards by 6.07% to $1.92. Exicure's trading volume hit 709.9K shares by close, accounting for 166.46% of its average volume over the last 100 days. The company's market cap stands at $168.9 million.
- Kiniksa Pharmaceuticals KNSA shares moved upwards by 4.74% to $17.0. The company's market cap stands at $1.1 billion.
- Alector ALEC stock increased by 4.34% to $26.44. The market value of their outstanding shares is at $2.1 billion.
- Cano Health CANO shares increased by 3.91% to $11.95. This security traded at a volume of 236.2K shares come close, making up 15.38% of its average volume over the last 100 days. The company's market cap stands at $5.7 billion.
Losers
- Avidity Biosciences RNA shares fell 7.91% to $19.0 during Monday's after-market session. The market value of their outstanding shares is at $714.6 million.
- SCWorx WORX shares decreased by 3.83% to $2.26. Trading volume for this security closed at 81.8K, accounting for 1.91% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $22.6 million.
- Hancock Jaffe HJLI stock decreased by 3.81% to $6.32. The market value of their outstanding shares is at $53.8 million.
- Erytech Pharma ERYP stock fell 3.73% to $6.21. The company's market cap stands at $164.0 million.
- Allied Healthcare Prods AHPI stock declined by 3.61% to $8.56. The market value of their outstanding shares is at $34.3 million.
- Xenetic Biosciences XBIO stock decreased by 3.59% to $4.3. This security traded at a volume of 170.4K shares come close, making up 2.0% of its average volume over the last 100 days. The market value of their outstanding shares is at $37.6 million.
Market News and Data brought to you by Benzinga APIs
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in